Research map: Feasibility and outcomes of crossflow membrane plasmapheresis for long COVID in Suriname: a randomized double-blind placebo-controlled pilot trial

Back to the article

Papers in this map

  1. The MOS 36-ltem Short-Form Health Survey (SF-36) · John E. Ware · 1992 · 30244 citations · Cited by this paper
  2. Effectiveness and Cost-effectiveness of Home-Based Occupational Therapy with Activity Monitoring for Daily Functioning of People Post-Stroke: Protocol for a Partially Randomised Usual Care Stepped-Wedge Trial · 2026 · Related
  3. Long COVID: major findings, mechanisms and recommendations · Hannah Davis · 2023 · 4329 citations · Cited by this paper
  4. Employing Fixed-Point Theory for Fuzzy Regression Analysis: Methodology and Empirical Application · 2026 · Related
  5. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact · Hannah Davis · 2021 · 3054 citations · Cited by this paper
  6. Leveraging Artificial Intelligence (AI) Based Algorithm for Accurate Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis in Breast Cancer Diagnostics: Potential to be a Crucial Aid in Routine Workflow · 2026 · Related
  7. Attributes and predictors of long COVID · Carole H. Sudre · 2021 · 2683 citations · Cited by this paper
  8. Documented Health System and Clinician-related Challenges among Neonatal Deaths at a Rural District Hospital, Eastern Cape, South Africa: A Retrospective Descriptive Study (2019–2025) · 2026 · Related
  9. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome · Ted Jack Kaptchuk · 2008 · 1209 citations · Cited by this paper
  10. Audit Quality in Action: How It Shapes Company Value Amid Profitability Challenges · 2026 · Related
  11. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial · Peter Denton White · 2011 · 908 citations · Cited by this paper
  12. PEPTIDE IDR-1002 REGULATES THE ANTIOXIDANT AND ANTI-INFLAMMATORY RESPONSES BY ACTIVATING THE KEAP1-NRF2 SIGNALING PATHWAY · 2026 · Related
  13. Psychometric qualities of a brief self-rated fatigue measure · Helen J. Michielsen · 2003 · 872 citations · Cited by this paper
  14. From ESP-Permissive to ESP-Driven: Recontextualizing English in Indonesia’s Vocational Curriculum · 2026 · Related
  15. Placebo interventions for all clinical conditions · Asbjørn Hróbjartsson · 2010 · 770 citations · Cited by this paper
  16. Accuracy of Systemic Inflammatory Indices in Identifying Neonatal Sepsis in Preterms in a Tertiary Care Hospital in Mangalore · 2026 · Related
  17. Measuring fatigue in clinical and community settings · Matteo Cella · 2009 · 388 citations · Cited by this paper
  18. Comparative Effectiveness of Progressive Muscle Relaxation, Autogenic Training, and Combined Therapy on Blood Pressure Among Older Adults with Hypertension: A Quasi-Experimental Study · 2026 · Related
  19. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature · Anthony L. Komaroff · 2023 · 340 citations · Cited by this paper
  20. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease · Franziska Sotzny · 2018 · 283 citations · Cited by this paper
  21. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome · Madlen Loebel · 2015 · 253 citations · Cited by this paper
  22. The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis · Hyong Jin Cho · 2005 · 114 citations · Cited by this paper
  23. Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME · Carmen Scheibenbogen · 2018 · 113 citations · Cited by this paper
  24. B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome · Øystein Fluge · 2019 · 92 citations · Cited by this paper
  25. Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis · Martin Achleitner · 2023 · 56 citations · Cited by this paper
  26. Therapeutic Plasmapheresis: A Revision of Literature · Claudia Altobelli · 2022 · 44 citations · Cited by this paper
  27. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption · Markus Tölle · 2020 · 42 citations · Cited by this paper
  28. Historical Perspective on Plasmapheresis · HELEN E. KAMBIC · 1997 · 22 citations · Cited by this paper
  29. Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis/chronic fatigue syndrome and elevated β2-adrenergic receptor autoantibodies: a prospective cohort study · Elisa Stein · 2024 · 21 citations · Cited by this paper
  30. Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial · Sergio España-Cueto · 2025 · 18 citations · Cited by this paper
  31. Immunoadsorption to treat patients with severe post‐COVID syndrome · Benjamin Giszas · 2023 · 15 citations · Cited by this paper
  32. A causal link between autoantibodies and neurological symptoms in long COVID · Keyla Santos Guedes de Sá · 2026 · 12 citations · Cited by this paper
  33. Clinical Applications of Therapeutic Hemapheresis · Sarah Rososhansky · 1996 · 10 citations · Cited by this paper
  34. An In Vitro Pilot Study Comparing the Novel HemoClear Gravity-Driven Microfiltration Cell Salvage System with the Conventional Centrifugal XTRA™ Autotransfusion Device · Anneloes Hoetink · 2020 · 10 citations · Cited by this paper
  35. Long COVID: mechanisms of disease, multisystem sequelae, and prospects for treatment · Seiya Oba · 2025 · 7 citations · Cited by this paper
  36. A Single-Center Pilot Study of Therapeutic Apheresis in Patients with Severe Post-COVID Syndrome · Johannes Korth · 2024 · 7 citations · Cited by this paper
  37. Case Report: Therapeutic and immunomodulatory effects of plasmapheresis in long-haul COVID · DOBRI D. KIPROV · 2022 · 6 citations · Cited by this paper
  38. Therapeutic plasma exchange in critically ill patients in low-income and lower-middle-income countries: medical need and feasibility · Rosita Bihariesingh-Sanchit · 2025 · 6 citations · Cited by this paper
  39. Clinical Remission After Therapeutic Apheresis in a Patient Suffering from Long Term Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Case Report · Harald Burgard · 2024 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)